Rifampicin-induced thrombocytopenia in a patient of disseminated tuberculosis

Authors

DOI:

https://doi.org/10.32677/ijcr.v8i6.3463

Keywords:

Rifampicin, THROMBOCYTOPENIA, TUBERCULOSIS

Abstract

Thrombocytopenia may be associated with a variety of conditions and risks depending on its severity, ranging from mild epistaxis to
life-threatening bleeding. Many drugs or herbal remedies can cause thrombocytopenia by either inhibiting platelet production and/or
enhancing their destruction from the peripheral blood-mediated through an immunological mechanism implicating drug-dependent
antibodies. Drugs are a common cause of acute immune-mediated thrombocytopenia in adults, the drug etiology is often initially
unrecognized. Most cases of drug-induced thrombocytopenia are caused by drug-dependent antibodies that are specific for the drug structure and bind tightly to platelets by their Fab regions but only in the presence of the drug. Thrombocytopenia is an uncommon but life-threatening complication of certain antitubercular drugs. The discovery of isolated thrombocytopenia in a patient taking several medications presents a challenging clinical problem. We report a case of a young immunocompetent female who presented with disseminated tuberculosis and was found to have rifampicin-induced thrombocytopenia.

Downloads

Download data is not yet available.

Downloads

Published

2022-07-13

Issue

Section

Case Report

How to Cite

Rifampicin-induced thrombocytopenia in a patient of disseminated tuberculosis. (2022). Indian Journal of Case Reports, 8(6), 176-178. https://doi.org/10.32677/ijcr.v8i6.3463

Most read articles by the same author(s)

<< < 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 > >>